Eniya Beemarajan
Role not yet determined Is this you? Add your title
Also affiliated: Arkansas Children's Hospital (2023–2024)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Eniya Beemarajan's research focuses on pediatric neurological disorders, particularly dystonia and neurodevelopmental conditions. She has published on KMT2B-related dystonia in children, investigating its presentation and progression. Her work also includes studies on SLC6A1-related neurodevelopmental disorder, exploring its response to phenylbutyrate treatment in a familial context. Beemarajan has also contributed to understanding autoimmune encephalitis and GAD65 antibody-associated epilepsy in pediatric and young adult populations through case series and literature reviews. Additionally, her publications address adverse events related to gene therapy, such as acute liver injury following delandistrogene moxeparvovec administration. Her collaborative efforts include work with Aravindhan Veerapandiyan, Praveen Kumar Ramani, Ruthwik Duvuru, and Megan W. Butler at the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications.
Metrics
- h-index: 2
- Publications: 5
- Citations: 12
Selected Publications
-
Phenylbutyrate-Responsive SLC6A1 -Related Neurodevelopmental Disorder Associated With a Familial Variant (2026)
-
GAD65 Antibody–Associated Epilepsy and Autoimmune Encephalitis in Children and Young Adults: A Single-Center Case Series and Review of Literature (2026)
-
Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin (2024)
Collaboration Network
Top Collaborators
- GAD65 Antibody–Associated Epilepsy and Autoimmune Encephalitis in Children and Young Adults: A Single-Center Case Series and Review of Literature
- Phenylbutyrate-Responsive SLC6A1 -Related Neurodevelopmental Disorder Associated With a Familial Variant
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin
- GAD65 Antibody–Associated Epilepsy and Autoimmune Encephalitis in Children and Young Adults: A Single-Center Case Series and Review of Literature
- GAD65 Antibody–Associated Epilepsy and Autoimmune Encephalitis in Children and Young Adults: A Single-Center Case Series and Review of Literature
- Phenylbutyrate-Responsive SLC6A1 -Related Neurodevelopmental Disorder Associated With a Familial Variant
- Phenylbutyrate-Responsive SLC6A1 -Related Neurodevelopmental Disorder Associated With a Familial Variant
Similar Researchers
Based on overlapping research topics